Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.

Bibliographic Details
Title: Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.
Authors: Kedaigle, Amanda J, Reidling, Jack C, Lim, Ryan G, Adam, Miriam, Wu, Jie, Wassie, Brook, Stocksdale, Jennifer T, Casale, Malcolm S, Fraenkel, Ernest, Thompson, Leslie M
Source: Human Molecular Genetics; 1/15/2020, Vol. 29 Issue 2, p202-215, 14p
Database: Complementary Index
More Details
ISSN:09646906
DOI:10.1093/hmg/ddz264
Published in:Human Molecular Genetics
Language:English